A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)
Public ClinicalTrials.gov record NCT05706506. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Single-Arm, Phase 4 Study to Assess Glycemic Control When Adults With Type 2 Diabetes Switch From a GLP-1 RA to Tirzepatide (SURPASS-SWITCH-2)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to investigate the effects of switching from glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy to tirzepatide glucose-dependent insulinotropic polypeptide (GIP) GLP-1 RA agonist in participants with type 2 diabetes (T2D).
Study identification
- NCT ID
- NCT05706506
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 152 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 7, 2023
- Primary completion
- Oct 30, 2023
- Completion
- Oct 30, 2023
- Last update posted
- Dec 12, 2024
2023
United States locations
- U.S. sites
- 32
- U.S. states
- 16
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Fiel Family and Sports Medicine PC | Tempe | Arizona | 85283 | — |
| New Hope Research Development | Corona | California | 92882 | — |
| Velocity Clinical Research, Gardena | Gardena | California | 90247 | — |
| Velocity Clinical Research, Huntington Park | Huntington Park | California | 90255 | — |
| Velocity Clinical Research, Huntington Park | Los Angeles | California | 90057 | — |
| Valley Clinical Trials, Inc. | Northridge | California | 91325 | — |
| Dream Team Clinical Research | Pomona | California | 91767 | — |
| Scripps Whittier Diabetes Institute | San Diego | California | 92121-1520 | — |
| Metabolic Institute of America | Tarzana | California | 91356-3551 | — |
| CMR of Greater New Haven, LLC | Waterbury | Connecticut | 06708 | — |
| Velocity Clinical Research, Hallandale Beach | Hallandale | Florida | 33009 | — |
| East Coast Institute for Research, LLC | Jacksonville | Florida | 32204 | — |
| Florida Institute For Clinical Research, LLC | Orlando | Florida | 32825 | — |
| New Tampa Health | Tampa | Florida | 33603-3402 | — |
| Georgia Clinical Research | Lawrenceville | Georgia | 30044-5896 | — |
| Endocrine Research Solutions, Inc. | Roswell | Georgia | 30076 | — |
| Velocity Clinical Research, Valparaiso | Valparaiso | Indiana | 46383 | — |
| Iowa Diabetes and Endocrinology Research Center | West Des Moines | Iowa | 50265 | — |
| Cotton O'Neil Clinic | Topeka | Kansas | 66606 | — |
| Versailles Family Medicine | Versailles | Kentucky | 40383-1947 | — |
| Endocrine and Metabolic Consultants | Rockville | Maryland | 20852 | — |
| Clinical Research Professionals | Chesterfield | Missouri | 63005 | — |
| Clinical Research of South Nevada | Las Vegas | Nevada | 89121 | — |
| Palm Research Center Tenaya | Las Vegas | Nevada | 89128 | — |
| Advanced Medical Research | Maumee | Ohio | 43537-9402 | — |
| Conrad Clinical Research | Edmond | Oklahoma | 73013 | — |
| Mountain View Clinical Research, Inc. | Greenville | South Carolina | 29607 | — |
| Texas Diabetes & Endocrinology, P.A. | Austin | Texas | 78731-4309 | — |
| North Texas Endocrine Center | Dallas | Texas | 75231 | — |
| Memorial City Endocrine Consultants | Houston | Texas | 77043-2742 | — |
| Consano Clinical Research, LLC | Shavano Park | Texas | 78231 | — |
| ClinPoint Trials | Waxahachie | Texas | 75165 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05706506, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 12, 2024 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05706506 live on ClinicalTrials.gov.